Market Overview:
The global organ transplant immunosuppressant market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of organ failures, rising demand for organ transplants, and technological advancements in the field of organ transplantation. The global market for organ transplant immunosuppressants is segmented on the basis of type into tacrolimus, mycophenolate mofetil, cyclosporin, and others. The tacrolimus segment is expected to account for the largest share of the global market in 2018. This segment is also projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. This growth can be attributed to its high efficacy and safety profile compared with other types of immunosuppressants available in the market.
Product Definition:
An organ transplant immunosuppressant is a medication that helps to prevent the body from rejecting a transplanted organ. These medications are important because they help to ensure that the transplanted organ remains healthy and functioning properly.
Tacrolimus:
Tacrolimus is an immunosuppressive drug that reduces the inflammatory response caused by the immune system. It is used to prevent organ transplant rejection and also for treatment of autoimmune disorders such as rheumatoid arthritis.
Mycophenolate Mofetil:
Mycophenolate mofetil is a myco-antibiotic and immunosuppressive drug used in the treatment of organ transplant rejection. It works by decreasing the ability of white blood cells to fight infection by inhibiting protein synthesis in them.
Application Insights:
Based on the application, the global organ transplant immunosuppressant market is segmented into liver transplant, kidney transplant, heart transplant and other organ transplants. Liver Transplant held the largest share in 2017 owing to increasing prevalence of chronic liver diseases such as non-alcoholic Steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and alcoholic liver disease. In addition, growing number of patients waiting for a donor livers increases demand for immunosuppressive drugs during surgery.
The Kidney Transplant application segment is expected to grow at fastest rate over forecast period due to rising incidence of chronic kidney diseases that require a lifelong medication after dialysis or a kidney transplantation. Moreover, an increase in healthcare spending by government authorities will boost industry growth over forecast period along with technological advancements that enhance efficiency of surgeries performed using these drugs during kidney transplants.
Regional Analysis:
North America dominated the global organ transplant immunosuppressant market in 2016. This can be attributed to the increasing prevalence of kidney and liver diseases, rising healthcare expenditure, better reimbursement scenario, and improved access to advanced therapies. The presence of sophisticated healthcare infrastructure coupled with high adoption of newer technologies is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving economic conditions in emerging countries such as India & China and growing awareness about organ donation activities. Moreover, a rise in chronic diseases leading to an increase in demand for organ transplants will further propel regional market development during the estimated time span (2018-2030).
Growth Factors:
- Increasing incidence of organ transplantation procedures across the globe is expected to drive the demand for organ transplant immunosuppressants over the forecast period.
- Rising awareness about benefits of organ transplants is anticipated to fuel growth of the market.
- Technological advancements in organ transplant surgeries are projected to create opportunities for market players operating in this space.
- Growing number of research and development activities for novel immunosuppressant drugs is likely to propel demand for these drugs in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Organ Transplant Immunosuppressant Market Research Report
By Type
Tacrolimus, Mycophenolate Mofetil, Cyclosporin, Others
By Application
Liver Transplant, Kidney Transplant, Heart Transplant, Other Organ Transplant
By Companies
Roche, Astellas Pharma Inc., Huadong Pharmaceutical, Novartis, Catalent Pharma, Cinkate Corporation, Cilag, Genzyme, Changzhou Pharm, North China Pharmaceutical Group Corporation, SL PHARM, Livzon Pharmaceutical Group Inc.,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Organ Transplant Immunosuppressant Market Report Segments:
The global Organ Transplant Immunosuppressant market is segmented on the basis of:
Types
Tacrolimus, Mycophenolate Mofetil, Cyclosporin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Liver Transplant, Kidney Transplant, Heart Transplant, Other Organ Transplant
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Astellas Pharma Inc.
- Huadong Pharmaceutical
- Novartis
- Catalent Pharma
- Cinkate Corporation
- Cilag
- Genzyme
- Changzhou Pharm
- North China Pharmaceutical Group Corporation
- SL PHARM
- Livzon Pharmaceutical Group Inc.,
Highlights of The Organ Transplant Immunosuppressant Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tacrolimus
- Mycophenolate Mofetil
- Cyclosporin
- Others
- By Application:
- Liver Transplant
- Kidney Transplant
- Heart Transplant
- Other Organ Transplant
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Organ Transplant Immunosuppressant Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Organ transplant immunosuppressant is a medication that helps the body to fight off infection after an organ transplant. It can also help prevent the body from rejecting the new organ.
Some of the major companies in the organ transplant immunosuppressant market are Roche, Astellas Pharma Inc., Huadong Pharmaceutical, Novartis, Catalent Pharma, Cinkate Corporation, Cilag, Genzyme, Changzhou Pharm, North China Pharmaceutical Group Corporation, SL PHARM, Livzon Pharmaceutical Group Inc.,.
The organ transplant immunosuppressant market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Organ Transplant Immunosuppressant Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Organ Transplant Immunosuppressant Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Organ Transplant Immunosuppressant Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Organ Transplant Immunosuppressant Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Organ Transplant Immunosuppressant Market Size & Forecast, 2020-2028
4.5.1 Organ Transplant Immunosuppressant Market Size and Y-o-Y Growth
4.5.2 Organ Transplant Immunosuppressant Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tacrolimus
5.2.2 Mycophenolate Mofetil
5.2.3 Cyclosporin
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Liver Transplant
6.2.2 Kidney Transplant
6.2.3 Heart Transplant
6.2.4 Other Organ Transplant
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Organ Transplant Immunosuppressant Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Organ Transplant Immunosuppressant Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tacrolimus
9.6.2 Mycophenolate Mofetil
9.6.3 Cyclosporin
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Liver Transplant
9.10.2 Kidney Transplant
9.10.3 Heart Transplant
9.10.4 Other Organ Transplant
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tacrolimus
10.6.2 Mycophenolate Mofetil
10.6.3 Cyclosporin
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Liver Transplant
10.10.2 Kidney Transplant
10.10.3 Heart Transplant
10.10.4 Other Organ Transplant
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tacrolimus
11.6.2 Mycophenolate Mofetil
11.6.3 Cyclosporin
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Liver Transplant
11.10.2 Kidney Transplant
11.10.3 Heart Transplant
11.10.4 Other Organ Transplant
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tacrolimus
12.6.2 Mycophenolate Mofetil
12.6.3 Cyclosporin
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Liver Transplant
12.10.2 Kidney Transplant
12.10.3 Heart Transplant
12.10.4 Other Organ Transplant
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tacrolimus
13.6.2 Mycophenolate Mofetil
13.6.3 Cyclosporin
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Liver Transplant
13.10.2 Kidney Transplant
13.10.3 Heart Transplant
13.10.4 Other Organ Transplant
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Organ Transplant Immunosuppressant Market: Competitive Dashboard
14.2 Global Organ Transplant Immunosuppressant Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Astellas Pharma Inc.
14.3.3 Huadong Pharmaceutical
14.3.4 Novartis
14.3.5 Catalent Pharma
14.3.6 Cinkate Corporation
14.3.7 Cilag
14.3.8 Genzyme
14.3.9 Changzhou Pharm
14.3.10 North China Pharmaceutical Group Corporation
14.3.11 SL PHARM
14.3.12 Livzon Pharmaceutical Group Inc.,
